nafamostat has been researched along with ADPKD in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maruyama, H | 1 |
Miyakawa, Y | 1 |
Gejyo, F | 1 |
Arakawa, M | 1 |
1 other study available for nafamostat and ADPKD
Article | Year |
---|---|
Anaphylactoid reaction induced by nafamostat mesilate in a hemodialysis patient.
Topics: Anaphylaxis; Anticoagulants; Benzamidines; Equipment Failure; Female; Guanidines; Humans; Kidney Fai | 1996 |